Correction: Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction

Correction: Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction

Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction

Origin, structural characteristics, prevention measures, diagnosis and potential drugs to prevent and COVID-19 - Medwave

Regulation of angiotensin-converting enzyme 2 isoforms by type 2 inflammation and viral infection in human airway epithelium - Mucosal Immunology

Full article: In silico analysis of dietary polyphenols and their gut microbial metabolites suggest inhibition of SARS-CoV-2 infection, replication, and host inflammatory mediators

Identifying Key Determinants of SARS-CoV-2/ACE2 Tight Interaction

Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases, Cell Communication and Signaling

Does SARS-CoV-2 Bind to Human ACE2 More Strongly Than Does SARS-CoV?

SARS‐CoV‐2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells

SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation

Engineering an ACE2-Derived Fragment as a Decoy for Novel SARS-CoV-2 Virus